Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05221762

Accelerated Stress CMR in Coronary Artery Disease

Accelerated Cardiovascular Magnetic Resonance in Coronary Artery Disease

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
167 (estimated)
Sponsor
University of Leicester · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the diagnostic performance of an accelerated stress CMR protocol, comparing it with that of standard CMR assessment.

Detailed description

This is a prospective, single-centre diagnostic accuracy study comparing the diagnostic performance of (1) accelerated and (2) standard adenosine stress CMR scans in 167 patients with suspected coronary artery disease referred for invasive coronary angiography (which will serve as the reference standard - invasive FFR). The accelerated scan comprises accelerated cine and gadolinium imaging, with a standard stress scan (0.075mmol/kg gadolinium contrast). Subjects will undergo both scans pre-angiography (in randomised order), enabling a head-to-head comparison of diagnostic performance (diagnostic accuracy, sensitivity and specificity) for identifying functionally significant coronary disease (as defined by fractional flow reserve \<0.80). Objectives The primary objective is to determine, in patients with suspected angina, whether the accelerated CMR protocol achieves favourable diagnostic accuracy, using invasive FFR as the reference standard, and also compared with standard CMR assessment. Secondary objectives include comparing diagnostic performance of the accelerated CMR protocol with that of CT-FFR, a comparison of scan duration (overall and for each component - for standard and accelerated CMR), and patient tolerability and experience for each protocol (accelerated CMR, standard CMR and CTCA), as determined by a self-administered questionnaire rating patient comfort, symptoms experienced and perceived scan duration. Data analysis * Imaging data will be interpreted using the 16-segment American Heart Association (AHA) segmentation model * For visual assessment of perfusion, images will be analysed by two experienced cardiologists, acting independently (differences resolved by consensus). * For qualitative analysis, perfusion data will be analysed concurrently with late gadolinium images, with inducible ischaemia determined by the presence of a perfusion defect exceeding the area of scar. * For quantitative analysis, myocardial blood flow (MBF) will be quantified using inline Gadgetron data (flow maps providing segmental flows). * For qualitative analysis, ischaemia is defined as reversible hypoperfusion in two adjacent segments \[32-segment model\] exceeding the region of scar \[if present\], and for quantitative analysis, using a MBF threshold of 1.9ml/min/g.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCardiovascular magnetic resonance (CMR)Cardiovascular magnetic resonance (CMR) at 3 Tesla

Timeline

Start date
2021-07-01
Primary completion
2024-06-30
Completion
2025-11-30
First posted
2022-02-03
Last updated
2025-07-02

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05221762. Inclusion in this directory is not an endorsement.

Accelerated Stress CMR in Coronary Artery Disease (NCT05221762) · Clinical Trials Directory